Overview
TB-500 is a synthetic fragment of thymosin beta-4. The catalogue identifies the fragment sequence as Ac-LKKTETQ.
Research use onlySpecification publishedQualified users only
Tissue-signaling research · AGX-03
TB-500
The actin-binding thymosin fragment
$50
10 mg lyophilized vial$5.00/mg · research use only
Research use only · no human or veterinary use, consumption, administration, diagnosis, treatment, prevention, cosmetic use, or food use. Sold to qualified laboratory and analytical users.
Mechanism (research literature)
TB-500 is classified in actin and cytoskeleton research. The fragment and the full thymosin beta-4 protein are distinct molecular records.
Research context
TB-500 appears in thymosin-fragment and tissue-signaling literature.
Specification
Listed format10 mg lyophilized vial
SequenceAc-LKKTETQ · Tβ4 fragment
Molecular formulaNot a discrete formula
Molecular weight≈872 g/mol
Catalogue referenceAGX-03
Listed price$50
Key targetActin / cytoskeleton
Common questions
Is TB-500 the full thymosin beta-4 protein?
No. This record describes the Ac-LKKTETQ fragment.
How is it distinct from BPC-157?
They have different peptide sequences and are listed as separate molecular records.